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ABSTRACT 
DNA-Protein Cross-Linking 
by Pyrrolizidine Alkaloids 
by 
Gail L. Drew, Master of Science 
Utah State University, 1997 
Major Professor: Dr. Roger A. Coulombe, Jr. 
Program: Toxicology 
Pyrrolizidine alkaloids (PAs) are natural plant compounds found in hundreds of 
plant species worldwide and are reported to have cytotoxic, carcinogenic, antimitotic, and 
iii 
genotoxic activity. PAs are metabolized by the cytochrome P450 (CYP) system to the 
pyrrole or the N-oxide form. The pyrroles are bifunctional electrophilic alkylators that bind 
cellular nucleophiles such as DNA and proteins and disrupt normal cell processes, 
including DNA replication and gene transcription, and can cause megalocytosis. The 
pyrroles dehydrosenecionine (DHSN) and dehydromoncrotaline (DHMO) are among the 
most potent PA cross-linkers and inducers of megalocytosis. DHSN and DHMO-induced 
cross-links in cultured normal (MDBK) and neoplastic (MCF7) cells were analyzed by 
SDS-PAGE and Western blot and both were found to contain the protein actin. Actin is 
crucial to DNA replication and is known to be involved in cross-links induced by cis-
dichlorodiamrnine platinum II (cisplatin), a well known cross-linking drug used for the 
treatment of cancer. Actin cross-linking may explain the antimitotic, megalocytotic, and 
anticarcinogenic effects of PAs. 
Since protein cross-linking is an important mode of actionfor PAs, we were 
interested in what characteristics of the protein might make it a good nucleophilic target. 
iv 
Thus, further research was undertaken based on the hypothesis that cysteine residues, and 
specifically free sulfhydryl groups, are attractive targets for the bifunctional electrophilic 
alkylators DHSN and DHMO. Nucleophiles were selected for their abundance in the cell, 
their cysteine content, and their relationship to the documented side effects of PAs. Actin , 
glutathione (GSH), metallothionein, topoisomerase II , and cysteine were all found to 
cross-link with DHSN and DHMO in virro while methionine, with no free sulfhydryl 
groups, did not cross-link. 
Our results support the hypothesis that cysteine residues are a key characteristic of 
proteins that are cross-linked by PAs. The cross-links could have negative effects to the 
cell as in the case of binding actin or topoisomerase II to alter normal DNA processes and 
replication, or beneficial effects such as binding to electrophilic scavengers like GSH or 
metallothionine as a detoxifying mechanism. The nucleophiles we tested in virro and 
found to form cross-links with DHSN and DHMO may help to explain the antimitotic, 
carcinogenic, and anti carcinogenic effects of PAs. 
62 pages 
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CHAPTER! 
LITERATURE REVIEW 
PYRROLIZIDINE ALKALOIDS: OCCURRENCE AND TOXICITY 
Pyrrolizidine alkaloids (PAs) are natural plant compounds found worldwide in an 
estimated 6,000 plant species largely in the genera Senecio, Crotalaria, Heliotropium, and 
Sy mphytum. Some commonly known plants containing PAs include Tansy ragwort, 
Borage, Common groundsel , Dusty Miller, and Hounds-tongue (Cheeke 1989, Knight et 
a/. 1984, Smith and Culvenor 1981). These alkaloids are toxic, carcinogenic, antimitotic, 
and anticarcinogenic (Culvenor 1968, King eta/. 1987, Kuhara eta/. 1980, Mattocks 
1986). Animals are exposed to PAs through grazing, and humans are exposed through 
ingestion of herbal remedies or contaminated grain , milk, or honey (Smith and Culvenor 
1981, Stillman eta/. 1977). PAs cause liver damage, including veno-occlusive disease in 
humans, and megalocytosis, cirrhosis, and hepatoma in both humans and animals (McLean 
1970). In addition, PAs cause CNS disorders and gastrointestinal lesions in horses and 
pulmonary hypertension in horses and rats (Culvenor 1983, Mattocks and Legg 1980, 
McLean 1970). PAs cause significant losses to the livestock industry as well as many 
human deaths. PAs are also anticarcinogenic due to their ability to cross-link DNA and 
impede mitosis in rapidly dividing tumor cells, and some PAs have been examined as anti-
tumor agents through clinical trials (Hincks eta/. 1991 , King eta/. 1987, Kim 1994, 
Letendre eta/. 1981 ). 
Human illness and death due to PAs have been due largely to ingestion of 
traditional herbal remedies or folk medicines, including comfrey tea, Russian comfrey, 
coltsfoot, chaparral, Betony, and Gordoloba Yerba (Culvenor 1983, Huxtable 1980, 
Mattocks 1986, Smith and Culvenor 1981). In many cases the remedies were given to a 
child or infant or taken by a pregnant mother. In the United States, several infant deaths 
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have been attributed to Gordo/abo Yerba , a FA-containing herbal remedy often used by 
Mexican-Americans to treat coughs and colds (Bergeson 1993, Stillman era/. 1977). In 
one case an infant was born with veno-occlusive di sease because the mother took Tussilago 
Jarfara (Coltsfoot) tea, which contained the PA senecionine, throughout her pregnancy 
(Roulet eta/. 1988). An 18-month-old child, who had been given an herbal tea mixture 
containing Alpendosr (Adenosryles alliariae) that contains the PA seneciphylline since 3 
months of age, was diagnosed with portal hypertension with severe ascites (S perl eta/. 
1995). Symptoms of acute PA poisoning include nausea, emesis, abdominal pain , and 
distention , and finally veno-occlusive disease (Stillman eta/. 1977). 
FA-containing foods have also been responsible for widespread poisonings of 
people in Russia, Afghanistan, South Africa, Jamaica, and the West Indies (Cheeke 1989, 
Mattocks 1986, McLean 1970). Grains and cereals that have been contaminated with FA-
containing seeds are important routes of exposure in these countries. Cows that forage and 
bees that pollinate FA-containing plants produce contaminated milk or honey (Smith and 
Culvenor 1981 ). PA exposure through foods and herbal s is a risk factor for liver disease 
and deaths, especially in developing nations where foods may be contaminated and in areas 
where unregulated herbal remedies substitute for medical treatments. 
CHEMICAL STRUCTURE AND METABOLISM OF PAS 
Pyrrolizidine alkaloids have been classified into four structural groups: u, ~ 
unsaturated macrocyclic diesters (senecionine, seneciphylline, riddelline, retrorsine); 
saturated macrocyclic diesters (monocrotaline); open diesters (heliosupine, latifoline); and 
necine bases (retronicine). Structures of representative PAs and their metabolites are 
shown in Figure 1-1. Two structural components seem to be crucial to biological toxicity: 
the u,j3 unsaturation of the necic acid ester and Cl-C2 unsaturation of the neci ne base 
(Hincks era/. 199 1, Kim eta/. 1995, 1996, Mattocks 1986). 
Pyrrolizidine alkaloids themselves are not toxic per se but are metabolized by 
cytochrome P4.50 (CYP) mixed-function oxidases to highly toxic pyrroles or less toxic N-
oxides. Significant species differences exist in the pattern of metabolite formation. For 
example, resistant species such as sheep, goats, rabbits, and guinea pigs produce mainly 
the less toxic N-oxide, while susceptible species such as horses, cows, rats, mice , and 
hamsters produce more of the pyrrole (White eta/. 1973). Chemical conversion to the 
pyrrole occurs by allylic oxidation followed by CYP-mediated dehydration (Fig. l-2) 
(Mattocks 1968, Mattocks and White 1971). Once the pyrrole is formed, this reactive 
species can alkylate at the C7 or C9 position, cellular nucleophiles such as DNA or 
proteins. Thus, pyrroles are bifunctional electrophilic alkylators that can covalently bind 
essential cellular nucleophiles and lead to alterations in cellular function (Mattocks 1968, 
Robertson 1982). 
PA INTERACTION WITH CELLULAR NUCLEOPHILES 
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The biological activity of PAs seems to be related to the ability of PAs to cross-link 
DNA or cellular proteins, which can lead to clinical toxicity as well as the observed 
antimitotic effect. Cross-links may be DNA-DNA or DNA-protein associated (Hincks et 
al. 1991 , Kim eta/. 1993, Petry et al. 1986, Reed etal. 1988). Dehydromonocrotaline has 
been shown to alkylate mostly at its C9 position directly to a nitrogen atom on the 
nucleoside or nucleotide (Niwa et al. 1991). Others have shown pyrroles to most 
commonly alkylate theN' of deoxyguanosine residues at the 5'd(CG) sequence (Robertson 
1982, Woo et al. 1992). Macrocyclic diester PAs with a, ~ unsaturation (senecionine, 
seneciphylline, ridelline, retrorsine) appear to be the most potent cross-linkers as well as 
antimitotics, inducers of megalocytosis and inhibitors of cell growth in mammalian cell 
cultures (Hincks er al. 1991, Kim et al. 1993, Mattocks 1968, Mattocks and Legg 1980). 
Kim et al. (1993) found about 50% of the cross-links induced by PAs in cultured cells to be 
protein associated. Those authors also found that the electrophoretic pattern of the ?A-
induced DNA-protein complexes in these cells were similar to those fonned by other 
bifunctional alkylating agents such as the anticancer chemotherapeutics mitomycin C and 
cis-dichlorodiammine platinum (II) (cisplatin). Bulky DNA-protein cross-links are 
significant to the cell because they may be ineffectively repai red during DNA replication 
and cause deletion errors or mutations (Cosma et at. 1988, Oleinick et at. 1987). Cell 
processes may be altered by agents that fonn DNA-DNA or DNA-protein cross-links 
because proteins bound in the cross-link may be essential to cell function or replication. 
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Kim et at. (1995) found that the proteins associated with PA-induced cross-links in 
cultured bovine kidney epithelial cells are acidic in nature and in the molecular weight range 
of 40-60 kD. These authors postulated that actin may be one of the proteins involved in the 
cross-linking because actin (45 kD) is a cellular target for DNA-protein cross-links by 
similar compounds, although no conclusive data was shown. Actin is a nuclear, non-
histone protein but not nonnally bound to DNA and is important to cytokinesis and 
transcription (Rungger et at. 1979, Scheer et at. 1984). Actin is crucial to the final step of 
mitosis by enabling the mitotic spindle to contract in the center and separate the newly 
replicated cell (Voet and Voet 1990). Megalocytosis, or large cells which have replicated 
but are unable to divide, is a typical symptom of PA exposure (Fig. 1-3). Miller et at. 
(1991) found actin to be the major protein in nearly 20% of the DNA-protein cross-links 
induced by cisplatin or potassium chromate in Chinese hamster ovary cells. Actin-DNA 
cross-linking may help explain the antimitotic and anti carcinogenic side effects of PAs. 
One focus of this research is to detennine if actin is involved in PA-induced cross-links in 
nonnal and cancer cells. 
Integration of amino acids and/or proteins into DNA-protein complexes is a mode 
of action of some carcinogens. For example, trivalent chromium integrates residual 
peptides and amino acids nonnally associated with DNA into DNA-protein cross-links 
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fa nned in human oesteosarcoma cells in vitro (Salnikow eta/. 1992). Histidine , cysteine, 
and tyrosine were the predominant amino acids involved in the DNA cross-links fanned by 
trivalent chromium and proteins or peptides with a high proportion of these amino acids 
such as BSA and actin which were readily complexed into cross-links (Salnikow eta/. 
1992). 
Glutathione (GSH; L-y-glutamyl-L-cysteinylglycine) is a tripeptide which in liver is 
the most predominant nonprotein intracellular thiol (Meister and Anderson, 1983). GSH 
contains nucleophilic, free sulfhydryl groups, which efficiently react with the bifunctional 
electrophilic PAs. Reed eta/. (1992) found that adding GSH to a mixture of rat liver 
microsomes and the PA senecionine yielded the dehydrosenecionine-GSH conjugate. 
These workers concluded that GSH conjugation was a possible detoxification pathway for 
pyrrolic PAs, formed by the microsomal conversion of senecionine to the highly reactive 
dehydrosenecionine. Other researchers have found that dietary cysteine protects against PA 
toxicity by increasing hepatic GSH concentrations (Kim and Jones 1982, White 1976). 
Nigra and Huxtable ( 1992) found an association between hepatic GSH concentrations and 
released dehydromonocrotaline in perfused rat livers and concluded that GSH was involved 
in forming adducts with the PA metabolite. Researchers have also found that debydro-
monocrotaline reacts with cysteine and GSH at both acidic and physiological pH in vitro 
(Robertson eta/. 1977). Borges and Wetterhahn (1989) found that chromium-induced 
cross-linking of glutathione or cysteine to DNA to form DNA-protein complexes in vitro. 
The study described in this thesis will explore the role of several candidate nucleophiles , 
containing various proportions of cysteine or thiol groups, amino acids, and tripeptides 
such as GSH as possible targets for PA-induced DNA-protein cross-links in vitro. 
6 
PAS AND CANCER 
Pyrrolizidine alkaloids have been examined as possible antitumor agents in clinical 
phase I and phase II trials but hepatoxicity has limited their usefulness (King et al. 1987, 
Letendre eta/. 1981, Poster eta/. 1981). The antimitotic and antitumor properties of PAs 
have been linked to their DNA cross-link activity (Hincks eta/. 1991). Well-known 
antitumor agents such as cisplatin and mitomycin C form DNA-protein associated cross-
links and the proteins from these cross-links have a similar electrophoretic migration pattern 
to that seen from FA-exposed cells (Kim 1994). Mitomycin C has two alkylating sites and 
has a molecular geometry similar to that of macrocyclic PAs (Hopkins eta/. 1991 , Woo er 
a/. 1992). Since PAs have similarities to anticancer cross-linking agents such as cisplatin 
and mitomycin C, a more direct investigation of the nature of PA-induced protein cross-
links in actual cancer cells would be important to discerning the mechanism of action of 
these compounds as well as their potential development as anticarcinogens. Indeed, there 
is an acute need for more anticancer agents. Cisplatin, commonly used to treat ovarian, 
testicular, head and neck, bladder, and small cell lung carcinomas, is often ineffective in the 
long term due to acquired cell resistance (Zhen et al. 1992). Resistant human ovarian 
cancer cells have an increased ability to repair the interstrand DNA crosslink induced by 
cisplatin (Zhen era/. 1992). Other potential causes for resistance include elevated levels of 
intracellular GSH and metallothionein (Kelly eta/. 1988, Hamilton eta/. 1985). 
Metallothionein is a small protein located in the cytoplasm and in the nucleus and is 
thought to be the major storage protein for copper as well as a carrier for zinc and 
cadmium. It also may play a role as an antioxidant since it contains reduced tltiolate metal 
bonds (DaCosta Ferreira er al. 1993). Overexpression of metallotltionein confers 
resistance to anticancer drugs in vitro (Kelly er al. 1988). Metallotltionein is a likely target 
for cross-linking PAs because it contains 28% cysteine residues by weight (Nordberg era/. 
1972). There is a clear need for more effective cancer chemotherapeutics. Previous work 
in Dr. Roger Coulombe's laboratory at Utah State University has shown that the a, p 
unsaturated macrocyclic diester PAs are strong antimitotics yet relatively moderate 
cytotoxins (Hincks et al. 1991). Some PAs may prove to be attractive antitumor agents. 
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FIG. 1-3. Phase-contrast photomicrographs of normal and pyrrolizidine alkaloid-
treated MDBK cells showing megalocyte formation. Un treated control cells are shown in 
A and cells exposed to 500 11m dehydrosenecionine (DHSN) are shown in B. X 400. 
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CHAPTER II 
DNA-PROTEIN CROSS-LINKlNG INDUCED BY DEHYDRO-
MONOCROT ALINE AND DEHYDROSENECIONINE IN NORMAL 
(MDBK) AND NEOPLASTIC (MCF7) CELLS 
ABSTRACT 
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Pyrrolizidine alkaloids (PAs), which are natural compounds found in plants 
worldwide , are reported to be cytotoxic, carcinogettic, antimitotic, and genotoxic in vivo 
and in vitro. PAs are bifunctional electrophilic alkylators that bind cellular nucleophiles 
including DNA and proteins, and disrupt normal cell processes. Documented effects on 
cells treated with PAs is disruption of cell replication and megalocytosis. The macrocyclic 
PA metabolites, dehydrosenecionine (DHSN) and dehydromonocrotaline (DHMO), are 
among the most potent cross-linkers and inducers of megalocytosis. DHMO and DHSN-
induced cross-links in normal (MDBK) and neoplastic (MCF7) cells were analyzed by SDS 
PAGE and Western blot and both were found to contain the protein actin. In addition, 
mitomycin C, a DNA cross-linker used as a control in this experiment, also contained actin 
in the cross-links induced in both cell types. To our knowledge, actin cross-linking by 
mitomycin C has not been previoulsly documented. Researchers have shown other 
anticarcinogettic cross-linking drugs such as cisplatin to incorporate actin into nearly 20% 
of their cross-links. Actin cross-linking may explain the antimitotic, megalocytotic, and 
anticarcinogettic effects of PAs because actin is crucial to DNA replication. 
INTRODUCTION 
Pyrrolizidine alkaloids (PAs) are natural plant compounds found worldwide in an 
estimated 6,000 plant species largely in the genera Senecio, Crotalaria, Heliotropium, and 
Symphytum. PAs are toxic, carcinogettic, an timitotic, and anticarcinogenic (Culvenor 
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INTRODUCfiON 
Pyrrolizidine alkaloids (PAs) are natural plant compounds found worldwide in an 
estimated 6,000 plant species largely in the genera Senecio, Crotalaria, Heliotropium, and 
Symphytum. PAs are toxic, carcinogenic, antimitotic, and anticarcinogenic (Culvenor 
1968, King eta!. 1987, Kuhara eta!. 1980, Mattocks 1986) and cause liver damage, 
including veno-occlusive disease in humans, and megalocytosis, cirrhosis, and hepatoma 
in both humans and animals (McLean 1970). In addition, PAs cause CNS disorders and 
gastrointestinal lesions in horses and pulmonary hypertension in horses and rats (Culvenor 
1983, Mattocks and Legg 1980, McLean 1970). PAs are also anticarcinogenic due to their 
ability to cross-link DNA and impede mitosis in rapidly dividing tumor cells, and some 
PAs have been examined in clinical trials as anti-tumor agents (Hincks et al. 1991, King et 
a!. 1987, Kim 1994, Letendre eta!. 1981). 
Pyrrolizidine alkaloids have been classified into four structural groups: a, f3 
unsaturated macrocyclic diesters (senecionine, seneciphylline, riddelline, retrorsine); 
saturated macrocyclic diesters (monocrotaline); open diesters (heliosupine, latifoline); and 
necine base (retronicine) (see Fig. 1-1 ). Two structural components seem to be crucial to 
biological toxicity: the a,fl unsaturation of the necic acid ester and C l-C2 unsaturation of 
the necine base (Hincks eta!. 1991 , Kim et al. 1995; Mattocks 1986). Pyrrolizidine 
alkaloids themselves are not toxic per se but are metabolized by cytochrome P450 (CYP) 
mixed-function oxidases to highly toxic pyrroles or less toxic N-oxides. Chemical 
conversion to the pyrrole occurs by allylic oxidation followed by CYP-mediated 
dehydration (see Fig. 1-2) (Mattock 1968, Mattocks and White 1971). Once the pyrrole is 
formed, this reactive species can alkylate at the C7 or C9 position, cellular nucleophiles 
such as DNA or proteins. Thus, pyrroles are bifunctional electrophyllic alkylators that can 
covalently bind essential cellular nucleophiles and lead to alterations in cellular function 
(Mattocks 1968, Robertson 1982). Macrocyclic diester PAs with a, f3 unsaturation, 
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Pyrrolizidine alkaloids have been examined as possible antitumor agents in clinical 
phase I and phase II trials but hepatoxicity has limited their usefulness (King et al. 1987, 
Letendre et al. 1981, Poster et al. 1981). The antimitotic and antitumor properties of PAs 
have been linked to their DNA cross-link activity (Hincks et at. 1991). Well-known 
antitumor agents such as cisplatin and mitomycin C form DNA-protein associated cross-
links, the proteins from which have a similar electrophoretic migration pattern to that seen 
from PA-exposed cells (Kim 1994). Mitomycin C has two alkylating sites positioned at 
nearly the same distance apart as that of the two alkylating sites of macrocyclic PAs 
(Hopkins et al. 1991, Woo et at. 1992). Since PAs have similarities to anticancer cross-
linking agents such as cisplatin and mitomycin C, a more direct investigation of the nature 
of PA-induced protein cross-links in actual cancer cells would be important to discerning 
the mechanism of action of these compounds as well as their potential development as 
anticarcinogens. 
Pyrrolic PAs cross-link cellular proteins. For example, Kim et al. (1993) found 
approximately 50% of the cross-links induced by PAs in cultured cells are protein 
associated. Bulky DNA-protein cross-links are significant to the cell because they may be 
ineffectively repaired during DNA replication and cause deletion errors or mutations 
(Cosma et at. 1988, Oleinick et al. 1987). Kim et at. (1995) found that the proteins 
associated with PA-induced cross-links in cultured bovine kidney epithelial cells to be 
acidic in nature and in the molecular weight range of 40-60 kD. These authors postulated 
that actin (45 kD) may be one of the proteins involved in the cross-linking because this 
protein is a cellular target for DNA-protein cross-links by similar compounds. Actin is a 
nuclear, nonhistone protein but not normally bound to DNA and is important to cytokinesis 
and transcription (Rungger eta/. 1984, Scheer et al. 1984). Actin is crucial to the fmal step 
of mitosis by enabling the mitotic spindle to contract in the center and separate the newly 
replicated cell (Voet and Voet 1990). Megalocytosis, or large cells which have replicated 
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but are unable to divide , are typical symptoms of PA exposure (see Fig. 1-3). Miller et al. 
( 1991) found actin to be the major protein in nearl y 20% of the DNA-protein cross-links 
induced by cisplatin or potassium chromate in Chinese hamster ovary cells. Actin-DNA 
cross-linking may help explain the antimitotic and anticarcinogenic side effects of PAs. 
The purpose of this study is to determine if actin is involved in PA-induced cross-links in 
normal and cancer cells. 
MATERIALS AND METHODS 
Chemicals and Reagents 
Human breast cancer cells (MCF7) and Madine Darby bovine kidney epithelial cells 
(MDBK) were purchased from the American Type Culture Collection (Rockville, MD). 
Senecionine was kindly provided by Russell J. Molyneux, U.S.D.A.-A.R.S. , Albany, 
CA. Monocrotaline, minimum essential medium eagle (MEM), Hanks balanced salts 
(HBS), sodium pyruvate, anhydrous dimethylsulfoxide (DMSO), Tween 20, cisplatin, 
mitomycin C, a-skeletal actin, monoclonal anti-actin reactive against all actin isoforms 
(mouse ascites fluid clone AC-40), and normal goat serum were purchased from Sigma 
Chemical Co. (St. Louis, MO). Fetal bovine serum was obtained from Summit 
Biotechnology (Ft. Collins, CO). Sodium dithionite (N,S,04 ) was purchased from 
Eastman Kodak Company (Rochester, NY). DNAse I and SDS-PAGE molecular weight 
markers were purchased from Promega Corporation (Madison, WI). Laemmli sample 
buffer, secondary antibody (blotting grade affinity purified goat anti-mouse IgG 
horseradish peroxidase conjugate) and the silver staining kit were purchased from Bio-Rad 
(Hercules, CA). The chemiluminescent detection kit (ECL) was obtained from Amersham 
(Arlington Heights , IL), the nitrocellulose membrane (Nitrobind) was purchased from 
Micron Separations Inc. (Westborough, MA) and the reflection autoradiograph film from 
Dupont (Boston , MA). 
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Cell Culture and Treatment 
Cells were grown in MEM containing I mM sodium pyruvate and 10 % iron-
supplemented fetal bovine serum in an atmosphere of 95% air and 5% C02 at 37oc. 
Confluent MCF7 cells from passages 154-156 and MDBK cells from passages 122-130 
were rinsed in PBS, removed by scraping, and counted (Model FN counter, Coulter 
Electronics, Hialeah FL). Equal numbers of cells were used for each treatment; for MCF7 
cells, 2.2 x 107 ; and for MDBK cells, 6 x 107 were used. Viability of the cells was 
checked by trypan blue exclusion. 
Isolation of Nuclei 
Nuclei were isolated by a modification of the method of Ausubel et al. ( 1996). 
Briefly, cells were harvested, rinsed in PBS, then ali quoted into treatment tubes, 
centrifuged (1850 x g, 10 min. 4°C), and the pellet was resuspended in ice-cold hypotonic 
buffer (10 mM HEPES pH 7.9, 1.5 mM MgCI,, 10 mM KCI, 0.2 mM phenylmethyl-
sulfonyl flouride, 0.5 mM dithiothreitol). This suspension was again centrifuged ( 1850 x 
g, 5 min , 4°C) and the pellet was resuspended in hypotonic buffer and allowed to swell for 
I 0 min on ice and then homogenized by I 0 strokes on a Dounce homogenizer and 
centrifuged (2700 x g, 18 min, 4°C) to yield isolated nuclei for treatment. 
Preparation of Pyrrolic PAs 
Pyrroles (DHMO and DHSN) were prepared from their parent compounds by the 
method of Mattocks et al. (1989) Briefly, 100 mg of the parent compound in 15 ml of 
anhydrous DMSO was mixed with 125 mg of tetrachloro-1,2-benzoquinone in 15 ml 
anhydrous DMSO in a separatory funnel. Two ml of a base solution (1.4 g KOH, 40 mg 
NaBH4 in 2 ml cold H,O) was added and the mixture was shaken vigorously for 20 sec. 
The organic phase was filtered through activated charcoal through a single no. 595 filter 
paper (Schleicher and Schuell Inc., Keene, NH) into a beaker containing 0.5 g anhydrous 
NlloS04 . The solution was swirled for I min, filtered again to remove the Na2S04 , and 
then evaporated under a stream of N2 gas. The resulting pyrrole was resuspended in 
anhydrous DMSO, capped with N2 , and stored in the dark at -80°C. Pyrrole purity was 
checked by 'H NMR. 
Treatment of Nuclei and Isolation 
of DNA-Protein Cross-Links 
Nuclei were resuspended in HBS and treated with either DMSO, I mM DHMO, l 
mM DHSN, 4 mM cisplatin, or 400 J1M ntitomycin C. Chenticals were dissolved in 
DMSO and added to cultures at no more than I% of the incubation volume. DMSO, 
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DHMO, DHSN, or cisplatin was added directly to the nuclear suspension and then shaken 
gently for 4 hr at 37o C. Mitomycin C was added to the nuclei suspension and then 
reductively activated by a modification of the method of McGuinness et al. (1991). 
Briefly, 40 ,.U of a fresh , ice-cold, 25 rnM solution of N,S,04 in HBS was added to the 
treatment in five increments every 5 ntin (5 x 8 ,.U ) and kept under a stream of N2 for 
30 ntin on ice. The nuclei were incubated with activated mitomycin C for 3.5 hr on a 
shaker at 3 7oc . 
All cross-linking reactions were stopped by centrifugation (1850 x g, 5 min, 4°C), 
then rinsing the pellet twice in a solution of ice-cold PBS with 0.1 mM PMSF. Cross-
linked DNA was separated from non-cross-linked DNA by a modification of the method of 
Ban jar et al. (1984). Briefly, the treated nuclei were resuspended in 5 ml of lysing buffer 
(2% SDS, 50 mM Tris-HCI, 0.1 mM PMSF, pH 8.0) then mixed on a rotary stirrer for 7 
hr at room temperature and centrifuged at 100,000 x g for 17 hr at 22o C. The lysis and 
centrifugation steps were repeated, and the resulting DNA pellet was resuspended and 
homogenized (Dounce homogenizer) in 2 mM Tris-HCL with 0.1 mM PMSF, pH 7.0. 
The cross-linked samples were sonicated 4 times at 20% power (Fisher Sonic 
Dismembrator, Model 300, Fisher Scientific, St. Louis, MO) for 20 sec each at 0°C to 
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release proteins cross-linked to DNA. The amount of DNA was estimated 
spectrophotometrically (A.=260), then the samples were digested with 40 j.lg DNAse I /mg 
DNA for 1 hr at 37° C and then dialyzed (Spectra Por, Spectrum Medical Industries 
Inc., Houston TX) overnight at 4° C against sterile double distilled water. DNA and 
protein concentrations in each sample were estimated again spectrophotometrically. The 
samples were aliquoted into tubes, freeze dried, and stored at -80°C. Proteins that were 
cross-linked to 40 j.lg of DNA were electrophoresed on an I 1% running and 4.5% stacking 
SDS-PAGE gel. One half of the gel was silver stained and the other half transferred by 
semi-dry blotter (Buchler Instruments, Kansas City, MO) to a nitrocellulose membrane for 
immunoblotting. 
Imrmmodetection of Proteins in the 
DNA-Protein Cross-Links 
The nitrocellulose membrane was blocked overnight in a solution of 5% nonfat dry 
milk (Carnation), 1% normal goat serum and I% Tween 20 in phosphate buffered saline 
(PBS). The membrane was washed twice in PBS for 5 min and incubated 2 hr in a 1:500 
dilution of the primary antibody (monoclonal anti-actin) in PBS. The membrane was 
washed four times for 5 min (PBS, PBS with 0.5% Tween 20, PBS with 0.5% Tween 20, 
PBS) and then incubated 1 hr with the secondary antibody (I :40,000) in 5% nonfat dry 
milk dissolved in PBS. The membrane was washed again four times for 5 min (PBS, PBS 
with 0.5% Tween 20, PBS with 0.5% Tween 20, PBS), and then washed in 10 ml of 
chemiluminescent solution for 2 min, exposed to autoradiographic film and developed. 
The relative densities of the actin signal were read for each treatment group (DHMO, 
DHSN, mitomycin C and cisplatin) on a UV densitometer (Multimedia densitometer, 
Gilford-Coming, Corning, NY). 
Characterization of DNA Cross-linked 
Proteins from Nuclei 
RESULTS 
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In this experiment, SDS-PAGE was used to separate the proteins associated with 
DHMO and DHSN-induced cross-links in cell nuclei from both normal (MDBK) and 
neoplastic cells (MCF7). Figures II-I and II-2 show the electrophoretic pattern of proteins 
from DHMO, DHSN, mitomycin C, and cisplatin-induced DNA-protein cross-links for 
MDBK and MCF7 cells, respectively. The predominant cross-linked proteins from the 
pyrrole- (DHMO, DHSN) treated nuclei were generally in the 40-60 k:D range with major 
bands at 45-k:D and 55-k:D (Figs. II-1 and II-2). Proteins from the mitomycin C-induced 
cross-links exhibited a banding pattern similar to that for pyrrole-induced cross-links, and 
also had a protein band around 45-k:D (Figs. II-l and II-2). Proteins from the cisplatin-
induced DNA-protein cross-links exhibited a slightly different electrophoretic pattern than 
that of the pyrroles, but like the pyrroles had a protein band at 45-k:D. However, the 
DMSO treatment lane in both gels (Figs. II-I and II-2) also showed a band in the 45-k:D 
range. Protein banding patterns were nearly identical between normal (MDBK) and 
neoplastic cells (MCF7) for each treament type (DHMO. DHSN, mitomycin C, cisplatin) 
(Figs II-I and II-2). 
lmmunodetection of Proteins in DNA-Protein 
Cross/inks in Nuclei 
We wished to detennine if actin was present in DHSN and DHMO-induced DNA-
protein cross-links in normal (MDBK) and neoplastic (MCF7) cell nuclei. The silver-
stained gels did reveal bands in the 45-k:D range for all treatments for each cell type; 
however, a similar band at 45-k:D was evident in the DMSO (negative control) lane in both 
gels. We sought to clarify this by using immunodetection, a highly sensitive method. 
Immunodetection with a polyvalent anti-actin antibody revealed that actin was part of both 
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DHMO and DHSN-induced DNA-protein cross-links in nuclei from both cell types (Figs. 
11 -3 and 11-4). Actin was also detected in the mitomycin C and cisplatin-induced DNA-
protein cross-links in these nuclei (Figs. 11-3 and 11-4). Two immunoreactive signals 
appeared for the DHMO, DHSN, and mitomycin C and three signals from the MCF7 cells 
treated with cisplatin. In contrast, the MDBK cells had only one actin signal for the 
DHMO, DHSN, mitomycin C, and cisplatin trea tments. Densitometer scans revealed that 
the amount of actin cross-l inked to DNA was approximately the same between DHMO and 
DHSN-treated MDBK and MCF7 nuclei (Fig. !l-5). The amount of actin cross-linked to 
DNA in cisplatin treated nuclei was significantly greater than that in DHMO, DHSN, and 
mitomycin C in both cell types (Fig. Il-5). Mitomycin C cross-linked more actin than 
either of the pyrroles in both cell types. Nuclei treated with the vehicle (DMSO) did not 
show an actin signal for either cell type. 
DISCUSSION 
Pyrrolizidine alkaloids are strong bifunctional alkylators of cellular nucleophiles, 
including DNA and proteins (Hincks eta!. 1991 , Kim eta!. 1993, Wagner eta!. 1993). 
PA-induced DNA-protein cross-linking appears to be crucial to the bioactivity of PAs and a 
significant portion of these cross-links are protein associated (Kim et al. 1995). Formation 
of DNA-protein cross-links are important to the toxic, antimitotic, and carcinogenic effects 
of PAs and other known cross-linkers such as cisplatin (Banjar et al. 1984) and nitrogen 
mustard (Thomas et al. 1978). DNA-protein complexes induced by pyrrolic PAs have 
been previously documented in MDBK cells by SDS-PAGE and isoelectric focusing (Kim 
eta!. 1995). Kim etal. (1995) concluded that the protein actin, (45 kD, 5.4 PI) a nuclear, 
non-histone protein associated with transc ription and cytokinesis (Rungger et al. 1984, 
Voet and Voet 1990), may be one of the proteins associated with the cross-links. The 
objective of this study was to determine if actin is one of the nucleophilic targets in PA-
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induced cross-links in normal (MDBK) and neoplastic (MCF7) cells. We also used two 
PA types : DHSN, a strong cross-linker, and DHMO, a moderate cross-linker, to illustrate 
the differences in cross-linking potential. Previous research has shown that DHSN is a 
stronger cross-linker and more potent inducer of megalocytosis than DHMO (Kim et al. 
1993). 
SDS-PAGE analysis of the DHSN and DHMO-treated nuclei of both cell types 
showed a prominent protein band at 45 kD. Nuclei, rather than whole cells, were used in 
this experiment to remove any effect of cytoplasmic detoxifying mechanisms on the pyrrole 
as well as to focus on the involvement of nuclear actin. 
Actin appeared to be a component in the DHMO and DHSN-induced DNA-protein 
cross-links in both MDBK and MCF7 nuclei. The cross-links in the MDBK nuclei had a 
single actin signal with the same electrophoretic mobility as the actin standard. The cross-
links from the MCF7 nuclei consistently showed a different pattern from the MDBK cells 
in that there were two actin signals, the additional one having a slightly lower 
electrophoretic mobility. We believe that the second signal was actin bound in the PA-
induced cross-link. 
Agents known to cross-link DNA to proteins were used as standards to compare to 
the PAs used in our study. Cisplatin is known to cross-link actin to DNA (Miller et al. 
1991). In our system, cisplatin induced actin-DNA cross-links in nuclei from both cell 
types to a greater extent than the pyrrolic PAs. 
Mitomycin C was also used as a positive standard because when reductively 
activated, it is known to cross-link DNA and is structurally similar to PAs in that the 
distance between the two electrophilic sites on mitomycin Cis similar to the two sites on 
DHMO (Hopkins eta/. 1991). In addition, mitomycin C and DHMO have a similar base 
sequence specificity for binding to DNA bases (Weidner et al. 1990). Actin was also 
strongly present in the mitomycin C-induced cross-links in both the MDBK and MCF7 
nuclei. To our knowledge, actin has not been documented as a protein associated with 
mitomycin C-induced cross-links in cultured cells. 
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There were significant differences in the amount of actin in the DNA-protein cross-
links in nuclei treated with cisplatin, mitomycin C, DHSN, and DHMO, which could 
indicate that these agents have differing reactivities toward this protein. The order of 
potency of DNA-actin cross-linking was: cisplatin >mitomycin C » DHSN" DHMO. It 
is also possible that the differences observed may relate to the relative stability of these 
agents in aqueous meduim. 
Actin is the most predominant cytoplasmic protein in eukaryotic cells and can 
constitute up to 10% of their total protein (Voet and Voet 1990). However, nuclear actin 
plays an important role in cytokinesis. There was no involvement of cytoplasmic actin 
because isolated nuclei were used in this study. Therefore, the known role of PAs in 
mitotic inhibition and megalocyteformation (Kim etal. 1993, Hincks etal. 1991) may 
relate to the affinity of thi s toxin to cross-link DNA to nuclear actin. PA-treated cells are 
able to produce DNA, RNA, and proteins but are unable to divide (Hoorn etal. 1992). 
Futherrnore, PA-induced DNA-DNA and DNA-protein cross-links are resistant to repair 
and their related antimitotic effects are long lasting (Kim eta/. 1993, Wagner et al. 1993). 
Therefore, PAs may be of possible use in chemotherapy where drug resistance has 
occurred due to increased cellular repair of DNA-protein cross-links as in the case of 
cisplatin resistance in the treatment of ovarian tumors (Zhen et al. 1992). 
More research about the nature of PA-induced DNA-protein cross-links is needed. 
If the proteins such as actin discovered in these experiments or other nucleophiles involved 
in the cross-links are associated with either mitosis or gene regulation, it would help 
explain the antimitotic, anticarcinogenic, and carcinogenic effects of PAs. Further study 
should include Western blots probed with antibodies for other proteins or nucleophiles 
likely to be associated with PA-induced cross-links. The specific amino acid composition 
that makes these nucleophiles good targets for the electrophilic PAs and the base pair 
sequence that constitutes a specific binding site in DNA is the subject of further study 
currently underway in our laboratory at Utah State University. 
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FIG. ll-1. Electrophoretic separation of DNA-protein cross-links from MDBK nuclei 
treated with pyrrolic PAs. DNA-protein cross-links were separated on an I I% SDS-PAGE 
gel and stained with silver nitrate. All samples were standardized to 40 ~g of DNA. These 
data indicate protein bands mostly in the molecular weight range of 40-60 kD including a 
protein band at45 kD for the PA treatments (DHMO and DHSN), mitomycin C (MMC), 
and cisplatin (CP). 
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FIG. II-2. Electrophoretic separation of DNA-protein cross-links from MCF7 nuclei 
treated with pyrrolic PAs. DNA-protein cross-links were separated on an II % SDS-PAGE 
gel and stained with silver nitrate. All samples were standardized to 40 !J.g of DNA. These 
data indicate protein bands mostly in the molecular weight range of 40-60 kD including a 
protein band at45 kD for the PA treatment (DHSN), mitomycin C (MMC), and cisplatin 
(CP). 
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FIG. 11-3. Western blot analysis of DNA-protein cross-links from MDBK nuclei 
treated with pyrrolic PAs. DNA-protein cross-links were separated on an 11% SDS-PAGE 
gel and the blot was probed with monoclonal anti-actin. All samples were standardized to 
40 JJ.g of DNA. These data indicate a strong actin signal for the cisplatin and mitomycin C-
treated nuclei and a slight signal for the PA-treated nuclei. 
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FIG. 11-4. Western blot analysis of DNA-protein cross-links from MCF7 nuclei 
treated with pyrrolic PAs. DNA-protein cross-links were separated on an II % SDS-PAGE 
gel and the blot was probed with monoclonal anti-actin. All samples were standardized to 
40 J.lg of DNA. These data indicate a strong actin signal for the cisplatin and mitomycin C-
treated nuclei and a slight signal for the ?A-treated nuclei. 
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Fl G. 11-5. Relative density of acti n signals on the Westem blots for dehydromonocrotal ine 
(DHMO), dehydrosenecionine (DHSN), mitomycin C (MMC), and cisplatin (CP) treatments on 
MDBK and MCf7 cell nuclei as measured by densitometer. Densities were compared relative to 
the pyrrole treatments DHMO and DHSN which were equal in density in both cell types. Data 
indicates that cisplatin has the strongest actin signal at 4-21 times more dense, and the mitomycin C 
signal 2-9 more dense as the DHMO or DHSN treatment signals. 
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CHAPTER III 
DNA-PROTEIN CROSS-LINKJNG BY DEHYDROSENECIONINE AND 
DEHYDROMONOCROTALINE/N VfiRO 
ABSTRACT 
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Pyrrolizidine alkaloids (PAs), which are found in hundreds of plant species around 
the world, reportedly have cytotoxic, carcinogenic, antimitotic, and genotoxic activity. 
PAs are bifunctional electrophilic alkylators that disrupt normal cell processes by binding 
cellular nucleophiles such as DNA and proteins. The ability of six cellular nucleophiles, 
including cysteine, methionine, actin, glutathione, metallothionine, and topoisomerase, to 
bind with dehydrosenecionine (DHSN) or dehydromoncrotaline (DHMO) was tested in 
vitro. All of the nucleophiles except methionine were cross-linked by both DHSN and 
DHMO as evidenced by the gel shift assay. Common to all the nucleophiles tested was the 
presence of cysteine residues which would provide sulfhydryl groups for binding by the 
electrophilic PAs. Methionine, which was not bound by either DHSN or DHMO, contains 
no free sulhydral groups and thus supports our hypothesis that PAs disrupt normal cell 
processes such as mitosis by binding crucial proteins based in part on the free sulfhydryl 
content of these proteins. 
INTRODUCTION 
Pyrrolizidine alkaloids (PAs) are natural plant compounds found worldwide in an 
estimated 6,000 plant species largely in the genera Senecio, Crotalaria, Heliorropium, and 
Symphytum. These alkaloids are toxic, carcinogenic, antimitotic, and anti carcinogenic 
(Culvenor 1968, King etal. 1987, Kuhara et al. 1980, Mattocks 1986). Animals are 
exposed to PAs through grazing, and humans are exposed through ingestion of herbal 
remedies or contaminated grain, milk, or honey (Smith and Culvenor 1981, Stillman et al. 
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1977). PAs cause liver damage, including vena-occlusive disease in humans, and 
megalocytosis, cirrhosis, and hepatoma in both humans and animals (McLean 1970). PAs 
are also anticarcinogenic due to their ability to cross-link DNA and impede mitosis in 
rapidly dividing tumor cells, and some PAs have been examined as anti-tumor agents 
through clinical trials (Hincks et al. 1991, King et al. 1987, Kim 1994, Letendre et 
a/.1981). 
Pyrrolizidine alkaloids themselves are not toxic per se but are metabolized by 
cytochrome P450 (CYP) mixed-function oxidases to ltighly toxic pyrroles or Jess toxic N-
oxides (see Fig. l-1). Two structural components seem to be crucial to biological toxicity: 
the a,(\ unsaturation of the necic acid ester and C l-C2 unsaturation of the necine base 
(Hincks et al. 1991, Kim er at. 1995, Mattocks 1986). Chemical conversion to the pyrrole 
occurs by CYP-mediated dehydration followed by allylic oxidation (see Fig. l-2) (Mattocks 
1968, Mattocks and Wltite 1971). Once the pyrrole is formed, tltis reactive species can 
alkyl ate at its C7 or C9 position cellular nucleopltiles such as DNA or proteins. Thus, 
pyrroles are bifunctional electropltilic alkylators that can covalently bind essential cellular 
nucleopltiles and lead to alterations in cellular function (Mattocks 1968, Robertson 1982). 
The biological activity of PAs appears to be related to the ability of PAs to cross-
link DNA or cellular proteins, wltich can lead to clinical toxicity as well as the observed 
antimitotic effect. Cross-links may be DNA-DNA or DNA-protein associated (Hincks et 
al. 1991, Kim er al. 1993, Petry et al. 1986, Reed et al. 1988). One study found about 
50% of the cross-links induced by PAs in cultured cells to be protein associated (Kim et al. 
1993). Bulky DNA-protein cross-links are significant to the cell because they may be 
ineffectively repaired during DNA replication and cause deletion errors or mutations 
(Cosma et al. 1988, Oleinick et al. 1987). Cell processes may be altered by agents that 
form DNA-DNA or DNA-protein cross-links because proteins bound in the cross-link may 
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be essential to cell function or replication. 
We were interested in identifying some nucleophiles that might be likely targets for 
the electrophilic pyrroles, the characteristics of these nucleophiles that enable the PA-
induced cross-link to form, and the possible consequences to the cell. Thus we selected 
several nucleophiles based on their abundance in the cell , our hypothesis that sulfhydryl 
groups are important to formation of the cross-link, and the resulting consequences to the 
cell if these nucleophiles were involved in a pyrrole-induced cross-link. 
Integration of amino acids and/or proteins into DNA-protein complexes is a mode 
of action of some carcinogens. For example, trivalent chromium integrates residual 
peptides and amino acids normally associated with DNA into DNA-protein cross-links 
formed in human oesteosarcoma cells in vitro (Salnikow et al. 1992). Histidine, cysteine, 
and tyrosine were the predominant amino acids involved in the DNA cross-links formed by 
trivalent chromium, and proteins or peptides with a high proportion of these amino acids 
such as BSA and actin were readily complexed into cross-links (Salnikow et al. 1992). 
Dehydromonocrotaline reacts with cysteine and GSH at both acidic and physiological pH 
in vitro (Robertson et al. 1977). We chose to test cysteine for its ability to react as a 
nucleophile with two strong PA cross-linkers, dehydromonocrotaline (DHMO) and 
dehydrosenecionine (DHSN), based on previous research and the presence of sulfhydryl 
groups. Research in our laboratory has shown that DHSN is among the strongest PA 
cross-linkers due to the a,.fl unsaturation of the necic acid ester (see Fig.l-1) (Kim et al. 
1993). Dehydromonocrotaline, with only one unsaturated position in the necic acid ester 
(see Fig.l-1), is a good cross-linker but weaker than DHSN (Kim etal. 1993). This 
experiment illustrated the relative cross-linking abilities of these two PA metabolites with 
various nucleophiles. 
Previous research in our laboratory has shown that actin is strongly suspected to be 
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present in pyrrole-induced cross-li nks in cultured cells. Actin is also a cellular target for 
DNA-protein cross-links by cross-linkers such as cisplatin and potassium chromate (Miller 
eta/. 1991). Actin (45 kD) is a nuclear, nonhistone protein containing cysteine residues 
and is important to cytokinesis and transcription (Rungger et al. 1986, Scheer et al. 1984). 
Actin is crucial to the final step of mitosis by enabling the mitotic spindle to contract in the 
center and separate the newly replicated cell (Voet and Voet 1990). Megalocytosis, or large 
cells which have replicated but are unable to divide, is a typical symptom of PA exposure 
(see Fig. 1-3). Actin-DNA cross-linking may help explain the antimitotic and anti-
carcinogenic side effects of PAs and thus was tested in our study for its ability to cross-link 
with DHMO and DHSN. 
We also chose to test glutathione (GSH; L-y-glutamyl-L-cysteinylglycine) because 
it is abundant in cells and contains a nucleophilic, free sulfhydryl group that has been 
observed to efficiently react with the bifunctional electrophilic PAs (Robertson era/. 1977). 
GSH is a tripeptide, which in the liver is the most predominant nonprotein intracellular thiol 
(Meister and Anderson, 1983). Reed eta/. ( 1992) found that adding GSH to a mixture of 
rat liver microsomes and the PA senecionine yielded the dehydrosenecionine-GSH 
conjugate and they concluded that GSH conjugation was a possible detoxification pathway 
for pyrrolic PAs. Other researchers have found that dietary cysteine protects against PA 
toxicity by increasing hepatic GSH concentrations (Kim and Jones 1982, White 1976). 
Nigra and Huxtable ( 1992) found an association between hepatic GSH concentrations and 
released dehydromonocrotaline in perfused rat livers and concluded that GSH was involved 
in forming adducts with the PA metabolite. Borges and Wetterhahn (1989) found that the 
cross-linker chromium induced cross-linking of glutathione or cysteine to DNA to form 
DNA-protein complexes in vitro. Thus, formation of a GSH-PA cross-link could be a 
detoxification pathway for the PA metabolites and could help explain the observed 
anticarcinogenic effect. 
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We also tested metallothionein because it is thought to operate somewhat like GSH 
as an electrophile scavenger. It is a small protein located in the cytoplasm and in the 
nucleus and is the major storage protein for copper as well as a carrier for zinc and 
cadmium. It also may play a role as an antioxidant since it contains reduced thiolate metal 
bonds (Da Costa Ferreira eta!. 1993). Overexpression of metallothionein confers 
resistance to anticancer drugs in vitro (Kelly et al. 1988). Metallothionein contains 28 % 
cysteine residues by weight (Nordberg et al. 1972) and therefore could be a likely target for 
cross-linking PAs. 
The observed antimitotic and megalocytotic effect of PAs on cells may involve 
cross-linking proteins such as topoisomerase II (approx. 400 kD), an enzyme crucial to the 
formation of DNA by catalyzing negative supercoiling. When topoisomerase II is inhibited 
by drugs such as novobiocin, DNA replication cannot proceed (Voet and Voet, 1990). If 
bifunctional alkylating agents such as DHMO and DHSN can bind topoisomerase II, they 
may be able to impede DNA replication and alter normal DNA behavior. In summary, this 
study attempts to explain some of the observed effects of PA cross-linking by exploring 
the role of several candidate nucleophiles, containing various proportions of cysteine or 
thiol groups, as possible targets for PA-induced DNA-protein cross-links in vitro. 
MATERIALS AND MErHODS 
Chemicals and Reagents 
Hind Ill-digested I.-phage DNA was purchased from New England Biolabs 
(Beverly, MA) and senecionine was generously provided by Russell J. Molyneux, 
U.S.D.A. - A.R.S. (Albany, CA). Monocrotaline, a-skeletal actin, glutathione, cysteine, 
methionine, and metallothionine were purchased from Sigma Chemical Co. (St Louis, 
MO). Topoisomerase II was obtained from Promega Corporation (Madison, WI). 
Preparation ofPyrrolic PAs 
Pyrroles (DHMO and DHSN) were prepared from parent compounds by the 
method of Mattocks et al. (1989). Briefly, 100 mg of the parent compound in 15 ml of 
anhydrous DMSO was mixed with 125 mg oftetrachloro-1,2-benzoquinone in 15 ml 
anhydrous DMSO in a separatory funnel. Two ml of a base solution (1.4 g KOH, 40 ml 
NaBH, in 2 ml cold H,O) was added and the mixture was shaken vigorously for 20 sec. 
The organic phase was ftltered through activated charcoal through a single no. 595 filter 
paper (Schleicher and Schuell Inc., Keene, NH) into a beaker containing 0.5 g of 
anhydrous Na,SO,. The solution was swirled for 1 min, filtered again to remove the 
Na,SO,, and then evaporated under a stream of N2 gas. The resulting pyrrole was 
resuspended in anhydrous DMSO, capped with N2,and stored in the dark at -80° C. 
Pyrrole purity was checked by 'H NMR. 
DNA Cross-Link Studies 
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Various amino acids, tripeptides, or proteins were investigated for their ability to 
compete with DNA as a nucleophile in the pyrrole-induced cross-link as assessed by gel-
shift analysis. This method is based on the retarded mobility of DNA-DNA or DNA 
protein complexes compared to untreated, non-cross-linked DNA separated by agarose gel 
electrophoresis. Nucleophile competition was assessed at DNA:pyrrole:nucleophile ratios 
of 1:2.5 :0, 1:2.5:0.5, 1:2.5:1, 1:2.5:2, and 1:2.5:4 for DHMO and DHSN. The DNA 
was added first to the reaction, the nucleophile second, and fmally the pyrrole. DNA: 
pyrrole:nucleophile reactions were mixed by vortexing, centrifuged briefly (13,600 x g, 10 
sec, 22° C), capped with nitrogen, incubated for 2 hr at 0° C, and then directly separated on 
a 0.8% agarose gel electrophoresed at 50 V and stained with ethidiurn bromide (l~g/ml). 
DNA bands were then visualized on a transilluminator, then photographed on a Polaroid 
MP-4 camera system. 
RESULTS 
DNA-Protein Cross-Links in Hind Ill-digested 
A.- Phage Plasmid DNA 
The pyrroles dehydrosenecionine (DHSN) and dehydromonocrotaline (DHMO) 
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induced cross-links between Hind III-digested A. -phage DNA and nucleophiles in vitro as 
shown in the agarose gel-shift assay (Figures III-I through III-I2). In these experiments, 
the cross-linking is apparent by a reduction in the electrophoretic mobility of the DNA 
bands compared to those of the control. Complete cross-linking of the A.-phage DNA was 
seen as a single intense band at the top of the gel (Fig. III-II and III-I2, lanes 3-7). 
Increasing amoun ts of nucleophile were added to the DNA and pyrrole reaction to 
determine if a cross-linking preference was shown to either the DNA or the nucleophile in 
the reaction. 
Neither DMSO (lane I for all figures) nor the nucleophile alone (lane 2 for all 
figures) influenced the electrophoretic mobility of the DNA fragments (Figs. II-1 through 
II-I2). The pyrrole with DNA alone clearly induced a cross-link (lane 3, Figs. II-I 
through Il-12) as shown by the reduced electrophoretic mobility of the DNA as compared 
to control. As the ratio of nucleophile to DNA was increased in the reaction, the retarded 
shift induced by the DHSN or DHMO was partially overcome as illustrated by a 
progressive increase in electrophoretic mobility of the DNA fragments and reappearance of 
the DNA fragments. Cysteine was a readily cross-linked nucleophile by both DHSN (Fig. 
III- 1) and DHMO (Fig. III-2). For DHMO, cysteine was preferred over the plasmid DNA 
even at the lowest ratio of 1:0.5 (DNA: cysteine), causing a complete reappearance of the 
plasmid DNA (Fig. III-2, lane 4). Glutathione (Fig. III-3 and Fig. III-4) and 
topoisomerase (Fig. III- 9 and Fig. III-10) were also favorable targets for both DHSN and 
DHMO in this system. Slightly Jess favorable but still cross-linked by DHSN and DHMO 
were actin (Fi g. lll-5 and Fig. III-6) and metallothionein (Fig.III-7 and Fi g. III-8). 
Methionine, with no free sulfhydryl groups, was not cross-linked by either DHSN (Fig. 
III-11 ) or DHMO (Fig. III-12) even at the highest ratio of DNA to methionine (1:4). We 
confirmed that DHSN is a more potent DNA cross-linker than DHMO because a smaller 
amount of the nucleophile was required to overcome the cross-linking and produce a gel 
shift effect for DHMO (Lanes 4-6, Figs. III-1 through III-12). 
DISCUSSION 
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The anti proliferative, antimitotic, and carcinogenic effects of PAs may be explained 
by the fact that PAs could form bulky cross-links with proteins crucial to DNA replication, 
gene transcription, and cell replication. The purpose of this study was to test several 
cellular nucleophiles for their ability to cross-link and compete with DNA in the FA-
induced cross-linking reaction in vitro. The nucleophiles were chosen on the basis of their 
reported nucleophilic properties and their association with either mitosis, gene 
transcription, DNA replication, or carcinogenesis. We hypothesized that the relative 
number of cysteine residues in the nucleophile and thus the number of sulhydryl groups 
available for binding the electrophilic PA metabolites DHSN and DHMO was important to 
the ability of a protein to be cross-linked. We used the two PA metabolites DHSN and 
DHMO because both are known to cross-link DNA, but DHSN is a stronger cross-linker 
and more potent inducer of megalocytosis than DHMO (Kim eta!. 1993). It was of interest 
to see if these two PA metabolites had different cross-linking preferences to the 
nucleophiles we tested. 
Our results showed that the relative cross-linking ability of the nucleophiles tested 
with both DHMO and DHSN was cysteine> GSH >actin" topoisomerase;, 
metallothionein > methionine. The molecular weight and relative number of sulhydryl 
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groups available for binding was important to the formation of the cross-link as well as the 
observed effect in the gel shift assay. Cysteine was easily cross-linked by DHMO and 
DHSN. Cysteine contains a free sulfhydryl group, which presumably provides a good 
nucleophilic target for the electrophilic pyrroles DHMO and DHSN. To verify this 
hypothesis, we tested the amino acid methionine, which does not contain a free sulfhydryl 
group and found that it did not cross-link with DHMO or DHSN even at the highest 
methionine: DNA ratio (4:1). 
Salnikow er al. (1992) tested chrominum, a known DNA-protein cross-linker and 
found that the cross-linking activity of chromium was associated most frequently with 
cysteine and tyrosine compared to the other amino acids. Examining the involvement of 
actin, BSA, and histones, these workers postulated that chromium reacts with protein first, 
the selection determined in part by the amino acid composition of the proteins such as 
cysteine, tyrosine, or histidine, and then binds to DNA. Lin et al. (1992) found chromium-
and nickel -induced cross-links were most often associated with cysteine and histidine. 
Kim er al. ( 1995) found cysteine to be an important factor when they demonstrated that 
DHSN cross-linked the most easily with BSA, which contains a higher proportion of 
cysteine, over actin and myosin which have fewer cysteine residues. The number of 
cysteine residues and thus the number of free sulhydryl groups available for binding could 
be critical to the formation of the PA-induced protein cross-link. 
In this experiment we attempted to explain some of the observed cellular effects of 
PAs in terms of their known mode of operation, binding cellular nucleophiles. Based on 
our results that PAs bind cysteine but not methionine, we selected nucleophiles that contain 
free sulfhydryls, are abundant in the cell, and if bound in a PA-induced cross-link could 
induce some of the observed effects of PAs. To help explain the antimitotic and 
carcinogenic effects of PAs, we tested actin and topoisomerase II and found them both to 
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be cross-linked by DHMO and DHSN. In chapter II we demonstrated that actin is present 
in the DNA-protein cross-links induced by the pyrroles DHMO and DHSN and the 
standard cross-linkers cisplatin and mitomycin C in both norrnal (MDBK) and neoplastic 
(MCF7) cells. Miller eta!. ( 1991) found actin in nearly 20% of the cross-links induced by 
cisplatin in cultured Chinese hamster ovary cells. Actin is a nuclear, nonhistone protein, 
containing approximately 2% cysteine residues by number and thus could be an attractive 
target for PAs. In addition, actin is not normally bound to DNA and is important to 
cytokinesis and gene transcription (Rungger eta!. 1984, Scheer et at. 1984, Voet and Voet 
1990). 
We also found topoisomerase II to be readily cross-linked by DHMO and DHSN. 
Topoisomerase II is a protein crucial to the forrnation of DNA by catalyzing negative 
supercoiling and when inhibited by drugs such as novobiocin, DNA replication cannot 
proceed (Voet and Voet 1990). Topoisomerase II has also been found to be involved in 
modulating the superhelical structure of DNA in transcriptionally active regions that may be 
necessary for drug action (Wang 1985). Transcribed regions of DNA are the preferred 
target for several DNA-reactive molecules such as aflatoxin Bl (Irvine and Wogen 1983) 
and bleomycin and neocarzinostatin (Beckman et at. 1987). If bifunctional alkylating 
agents such as DHMO and DHSN can bind actin or topoisomerase II in the cell , this could 
explain in part the ability of PAs to impede DNA replication and alter norrnal DNA 
behavior. 
To explain the observed anti carcinogenic effects of PAs, we tested glutathione and 
meta!lothionein in our system and showed both to cross-link readily with DHMO and 
DHSN. Glutathione, a tripeptide that binds electrophilic species and allows them to be 
excreted from the body, is the most predominant intracellular thiol (Meister and Anderson 
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1983) and contains approximately 40% cysteine by weight. Glutathione has been shown to 
be invol ved in cross-links induced by standard cross-linkers in vitro such as chromium 
(Borges and Wetterhahn 1989) and dehydrosenecionine (Reed eta/. 1992), and the 
cysteine residues of glutathione are crucial to formation of GSH cross-links (Salnikow et 
a/. 1992). Metallothionein, found mainly in the cytoplasm and but also in the nucleus, is 
known to be associated with binding and transport of heavy metals such as cadmium and 
cooper and contains 28% cysteine residues (Nordberg eta/. 1972, West er a/. 1995). It has 
been suggested that metallotllloneins are free radical scavengers and protect the body 
somewhat like GSH against reactive electropllllic species. Elevated levels of intracellular 
glutathione (Hamilton eta/. 1985) and metallothionein (Kelly eta/. 1988) are known to be 
associated with resistance to drugs presumably because of the ability to bind the drug and 
make it excretable. We have shown glutatlllone and metallotlllonein to be molecular targets 
for formation of pyrrole cross-links in our system and formation of these complexes in the 
cell could deter the DNA cross-linking effect of pyrroles. 
In summary, our in vitro system has provided insight into some characteristics that 
make a protein an attractive target for PA-induced cross-linking. We hypothesized that the 
number of free cysteine residues and therefore the number of sulfhydryl groups that would 
be available for binding are key elements to formation of cross-links. The mode of action 
of PAs is the ability to form DNA-DNA or DNA-protein cross-links with cellular 
nucleoplllles and thus alter the normal cell processes. The cross-links induced by PAs 
could have negative effects to the cell as in the case of binding actin or topoisomerase II to 
alter normal DNA processes and replication or beneficial effects such as binding to 
electrophilic scavengers like GSH or metallotlllonine as a detoxifying mechanism. The 
nucleophiles we tested in vitro and found to form cross-links with DHMO and DHSN help 
explain the antimitotic, carcinogenic, and anticarcinogenic effects of PAs. 
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FIG. III- 1. Effect of cysteine on dehydrosenecion ine (DHSN)-induced DNA cross-links in 
Hind Ill -d igested A.-phage DNA at w:w:w ratios (DNA:DHSN:cystcinc) of I :2.5:0.5 (lane 4), 
I :2.5: I (lane 5), I :2.5:2 (lane 6), and I :2.5:4 (lane 7). Controls with vehicle (DMSO) are in lane I 
( I :2 .5:0) and lane 2 ( I :2.5:4), while lane 3 is DNA with DHSN only (I :2.5:0) and lane 8 is BST E 
11 -digested A.-phage DNA as a marker. Increasing amounts of cysteine in the reaction partiall y 
overcome the DHSN cross-linking effect on the DNA and can be seen as increased electrophoretic 
mobility of the DNA bands as compared to the control in lane 3. 
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FIG. 111-2. Effect of cysteine on dehydromonocrotaline (DHMO)-induced DNA cross-links 
in Hind Ill-digested A.-phage DNA at w:w:w ratios (DNA:DHMO: cysteinc) of I :2.5:0.5 (lane 4), 
I :2.5: I (lane 5), I :2.5:2 (lane 6), and I :2.5:4 (lane 7). Controls with vehicle (DMSO) are in lane I 
( I :2.5:0) and lane 2 ( 1:2.5:4), whi le lane 3 is DNA with DHMO onl y ( I :2.5:0) and lane 8 is BST 
E ll -digested t.-phage DNA as a marker. Increasing amounts of cysteine in the reaction partiall y 
overcome the DHMO cross-linking effect on the DNA and can be seen as increased electrophoretic 
mobility of the DNA bands as compared to the control in lane 3. 
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FIG. 111-3. Effect of glutathione on dehydrosenecionine (DHSN)-induced DNA cross-links 
in Hind III-digested A.-phage DNA at w:w:w ratios (DNA:DHSN:glutathione) of I :2.5:0.5 (Jane 
4), I :2.5:1 (lane 5), I :2.5:2 (lane 6) , and I :2.5:4 (lane 7). Controls with veh icle (DMSO) are in 
Jane I ( 1 :2.5:0) and Jane 2 ( 1 :2.5:4), while lane 3 is DNA with DHSN only ( 1 :2.5:0) and Jane 8 is 
BST Ell-digested A.-phage DNA as a marker. Increasing amounts of glutathione in the reaction 
partially overcome the DHSN cross-linking effect on the DNA and can be seen as increased 
electrophoretic mobility of the DNA bands as compared to the control in Jane 3. 
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F IG. 111- 4. Effect of glutathione on dehydromonocrotaline (DHMO)-induced DNA cross-
links in Hind Ill -digested A.-phage DNA at w:w:w ratios (DNA:DHMO:glutathione) of I :2.5:0.5 
(lane 4 ), I :2.5: I (lane 5), I :2.5:2 ( lane 6), and I :2.5:4 (lane 7). Controls with vehicle (DMSO) are 
in lane I (1 :2.5:0) and lane 2 (I :2.5:4), while lane 3 is DNA with DHMO only ( I :2.5:0) and lane 8 
is BST E 11-digested A.-phage DNA as a marker. Increasing amounts of glutathione in the reaction 
partially overcome the DHMO cross-linking effect on the DNA and can be seen as increased 
electrophoretic mobi lity of the DNA bands as compared to the control in lane 3 . 
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FIG. III-5. Effect of actin on dehydrosenecionine (DHSN)-induced DNA cross-links in 
Hind Ill-digested A.-phage DNA at w:w:w ratios (DNA:DHSN:actin) of 1:2.5:0.5 (lane 4), 1:2.5: I 
(lane 5), 1:2.5:2 (lane 6), and 1:2.5:4 (lane 7). Controls with vehicle (DMSO) are in lane 1 
(1:2.5:0) and lane 2 (1:2.5:4), while lane 3 is DNA with DHSN only ( 1:2.5:0) and lane 8 is BST E 
11-digested A.-phage DNA as a marker. Increasing amounts of actin in the reaction partially 
overcome the DHSN cross-linking effect on the DNA and can be seen as increased electrophoretic 
mobility of the DNA bands as compared to the control in lane 3. 
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FIG. 111·6. Effect of actin on dehydromonocrotaline (DHMO)-induced DNA cross-links in 
Hind Ill-digested A.-phage DNA at w:w:w ratios (DNA:DHMO:actin) of 1:2.5:0.5 (lane 4), I :2.5: l 
(lane 5), 1:2.5:2 (lane 6), and 1:2.5:4 (l ane 7). Controls with vehicle (DMSO) are in lane I 
( 1:2.5:0) and lane 2 (I :2.5:4), while lane 3 is DNA with DHMO only ( I :2.5:0) and lane 8 is BST 
E 11-digested A.-phage DNA as a marker. Increasing amounts of actin in the reaction partially 
overcome the DHMO cross-linking effect on the DNA and can be seen as increased electrophoretic 
mobility of the DNA bands as compared to the control in lane 3. 
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FIG. II I· 7 . Effect of metallothionein on dehydrosenecionine (DHSN)-induced DNA cross-
links in Hind Ill-digested A.-phage DNA at w:w:w ratios (DNA:DHSN: metallothionein) of 
I :2.5:0.5 (lane 4), I :2.5: I (lane 5), I :2.5:2 (lane 6), and I :2.5:4 (lane 7). Controls with vehicle 
(DMSO) are in lane I (1:2.5:0) and lane 2 (1:2.5:4), while lane 3 is DNA with DHSN only 
(I :2.5:0) and lane 8 is BST E 11-digested A.-phage DNA as a marker. Increasing amounts of 
metallothionein in the reaction partially overcome the DHSN cross-linking effect on the DNA and 
can be seen as increased electrophoretic mobility of the DNA bands as compared to the control in 
lane3. 
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FIG. 11 1-8. Effect of metallothionein on dehydromonocrotaline (DHMO)-induced DNA 
cross-links in Hind Ill-digested A-phage DNA at w:w:w ratios (DNA:DHMO:metallothionein) of 
I :2.5:0.5 (lane 4), 1:2.5: I (lane 5), I :2.5:2 (lane 6), and I :2.5:4 (lane 7). Controls with vehicle 
(DMSO) are in lane I (I :2.5:0) and lane 2 ( 1:2.5:4), while lane 3 is DNA with DHMO only 
(I :2.5:0) and lane 8 is BST E 11-digested A-phage DNA as a marker. Increasing amounts of 
metallothionein in the reaction partially overcome the DHMO cross-linking effect on the DNA and 
can be seen as increased electrophoretic mobility of the DNA bands as compared to the control in 
lane 3. 
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FIG. 111-9. Effect of topoisomerase on dehydrosenecionine (DHSN)-induced DNA cross-
links in Hind Ill-digested A-phage DNA at w:w:w ratios (DNA:DHSN:topoisomerase) of I :2.5:0.5 
(lane 4), 1:2.5: I (lane 5), 1:2.5:2 (lane 6), and I :2.5:4 (lane 7). Controls with vehicle (DMSO) are 
in lane 1 (1:2.5:0) and lane 2 (1 :2.5:4), while lane 3 is DNA with DHSN only ( 1:2.5:0) and Jane 8 
is BST E 11-digested A-phage DNA as a marker. Increasing amounts of topoisomerase in the 
reaction partially overcome the DHSN cross-linking effect on the DNA and can be seen as 
increased electrophoretic mobility of the DNA bands as compared to the control in lane 3. 
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FIG. 111-10. Effect of topoisomerase on debydromonocrotaline (DHMO)-induced DNA 
cross-links in Hind Ill-digested f.-phage DNA at w:w:w ratios (DNA:DHMO:topoisomerase) of 
1:2.5:0.5 (lane 4), 1:2.5: I (lane 5), I :2.5:2 (lane 6), and 1:2.5:4 (lane 7). Controls with vehicle 
(DMSO) are in lane I (I :2.5:0) and lane 2 (1:2.5:4) , while lane 3 is DNA with DHMO only 
(1 :2.5:0) and lane 8 is BST E 11-digested f.-phage DNA as a marker. Increasing amounts of 
topoisomerase in the reaction partially overcome the DHMO cross-linking effect on the DNA and 
can be seen as increased electrophoretic mobility of the DNA bands as compared to the control in 
lane3. 
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FIG. 111-11. Effect of methionine on dehydrosenecionine (DHSN)-induced DNA cross-links 
in Hind Ill-digested /,.-phage DNA at w:w:w ratios (DNA:DHSN: methionine) of 1:2.5:0.5 (lane 
4), I :2.5: I (lane 5), I :2.5:2 (lane 6), and I :2.5:4 (lane 7). Controls with verucle (DMSO) are in 
lane I (I :2.5:0) and lane 2 (1:2.5:4), while lane 3 is DNA with DHSN only (1:2.5:0) and lane 8 is 
BST E 11-digested A.-phage DNA as a marker. Increasing amounts of methionine in the reaction 
partially overcome the DHSN cross-linking effect on the DNA and can be seen as increased 
electrophoretic mobility of the DNA bands as compared to the control in lane 3. 
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FIG. 111-12. Effect of methionine on dehydromonocrotaline (DHMO)-induced DNA cross-
links in Hind III-digested A.-phage DNA at w:w:w ratios (DNA:DHMO: methionine) of I :2.5:0.5 
(lane 4), I :2.5: I (lane 5), I :2.5:2 (lane 6), and I :2.5:4 (lane 7). Controls with vehicle (DMSO) are 
in lane I ( 1 :2.5:0) and lane 2 ( 1 :2.5:4), while lane 3 is DNA with DHMO only ( 1 :2.5:0) and lane 8 
is BST E 11-digested A.-phage DNA as a marker. Increasing amounts of methionine in the reaction 
partially overcome the DHMO cross-linking effect on the DNA and can be seen as increased 
electrophoretic mobility of the DNA bands as compared to the control in lane 3 . 
CHAPTER IV 
SUMMARY 
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Pyrrolizidine alkaloids (PAs) are natural plant toxins found worldwide that exhibit 
cytotoxic, carcinogenic, anticarcinogenic, and antimitotic properties. PAs are metabolized 
by the P450 (CYP) system to the relatively nontoxic N-oxide form or the highly reactive 
pyrroles. Pyrroles are bifunctional electrophilic aikylators that bind cellular nucleophiles 
such as proteins or DNA and alter normal cell processes including DNA replication and 
transcription. The formation of DNA-DNA or DNA-protein cross-links in the cell is a key 
mode of action for PAs and could help explain the varying side effects of PAs. For 
example, proteins, key to mitosis or gene transcription, could be targets for pyrrole binding 
and would explain the antimitotic and carcinogenic effects of PAs. Other protein targets 
may be electrophilic scavengers and the formation of ?A-induced cross-links with these 
proteins may help explain the anlicarcinogenic effects of PAs. Experimental goals were to 
discover some of the proteins that are good cross-linking targets for the pyrroles and what 
characteristics make the protein an attractive cross-linking target. Therefore, 2 studies were 
conducted using the potent cross-linkers dehydromonocrotaline (DHMO) and dehydro-
senecionine (DHSN) to induce cross-links, first in cultured normal (MDBK) and neoplastic 
(MCF7) cells and then in an in vitro system utilizing the gel shift assay. 
In the first study, DHMO- and DHSN-induced cross-links in MDBK and MCF7 
nuclei were isolated, the DNA was digested off the cross-link, and the resulting proteins 
associated with the cross-links were separated by SDS-PAGE and probed for the presence 
of actin on a Western blot. Actin is ubiquitous, abundant, and not normally bound to DNA 
in the nucleus. Actin was chosen because of its critical role in mitosis, abundance in the 
cell, and previous research documenting actin cross-links with a similar electropbilic 
alkylator, cisplatin. Actin was found to be present in DHMO- and DHSN-induced cross-
links in both normal and neoplastic cells. In addition , actin was present in cisplatin- and 
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mitomycin C-induced cross-links used as positive controls. Although mitomycin Cis 
known to cross-link DNA, and is simi lar in structure to PAs with its two alkylating sites 
nearly the same distance apart as in the pyrroles, it has not been previously documented to 
cross-link actin. The presence of actin in the cross-links induced by DHMO, DHSN, 
cisplatin, and mitomycin C in both normal and neoplastic cells indicates that: I) all of these 
alkylators do cross-link proteins and 2) actin, critical to mitosis, when bound in a PA-
induced cross-link could be responsible for observed antimitotic effects on the cell such as 
megalocytosis. Results show the actin signals seen on both the MDBK and MCF7 blots 
are in fact actin alone or actin still cross-linked to some DNA (with less migration in the gel 
than the pure actin) because the Western blots were probed with a MAP antibody sensitive 
to all isoforms of actin. 
In the second experiment, proteins or nucleophiles were tested for their cross-
linking ability, based, in part, on the consequences to the cell if the nucleophile was bound 
in a cross-link. The hypothesis was that abundant cellular nucleophiles with cysteine 
residues could provide sulfhydryl groups for the electrophilic PAs to bind and form cross-
links. An in vitro system was developed using PAs to cross-link plasmid DNA and a 
chosen nucleophile. The cross-links were separated by agarose gel and when cross-linking 
occurred, an increased molecular weight and resulting slower migration were seen. As the 
ratio of nucleophile over DNA was increased, the DNA bands began to reappear, indicating 
that the PA was cross-linked more to the nucleophile than the DNA. The agarose gels were 
ethidium bromide stained, indicating the location of the DNA, but a future experiment 
would be to label the nucleophile to determine its location as well. Results indicate that 
cysteine alone cross-linked readily to both DHMO and DHSN while methionine, containing 
no free sulfhydryl groups, did not. Glutathione, actin, metallothinein, and topoisomerase, 
all containing sulfhydryl groups, were then tested and each of them was found to cross-link 
with DHMO and DHSN. The relative cross-linking abiltiy of the nucleophiles tested with 
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both DHSN and DHMO was: cysteine> GSH "actin> metallothionein" topoisomerase > 
methionine. The results also indicated that overall DHSN is a much stronger cross-linker 
than DHMO. PA-induced cross-linking to nucleophiles can be related to the known side 
effects of PAs. PA-actin cross-linking could explain the megalocytotic and antimitotic 
effects of PAs and verifies the results of the first experiment that actin is I of the proteins 
that can form cross-links with PAs. Glutathione and metallothionine both contain cysteine 
residues, which are known to act as electrophilic scavengers, and therefore could be 
potential detoxifiers of pyrroles. Topoisomerase II is crucial to DNA negati ve supercoiling 
and if bound in a cross-link, DNA replication and transcription could be affected. In 
summary, the cross-links induced by PAs could have negative effects to the cell as in the 
case of binding actin or topoisomerase II to alter normal DNA processes and replication, or 
beneficial effects such as binding to electrophilic scavengers like GSH or metallothionein as 
a detoxifying mechanism. 
More research about the nature of PA-induced DNA-protein cross-links is needed. 
If the proteins or nuc!eophiles, discovered in these experiments, such as actin, glutathione, 
metallothionein, and topoisomerase II , are involved in the cross-links and are associated 
with ei ther mitosis, gene regulation, or a detoxification mechanism, it would help explain 
the antimitotic, anti carcinogenic, and the carcinogenic effects of PAs. Future research 
should include Western blots probed with antibodies for other nucleophiles likely to be 
associated with PA-induced cross-links and a determination of the specific amino acid 
composition that makes these nucleophiles good targets for PA cross-linking. 
